A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumors.
Saved in:
| Title: | A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumors. |
|---|---|
| Authors: | Poklepovic AS; Massey Cancer Center.; Departments of Internal Medicine., Gordon SW; Massey Cancer Center.; Departments of Internal Medicine., Kothadia S; Massey Cancer Center.; Departments of Internal Medicine., McGuire WP; Massey Cancer Center.; Departments of Internal Medicine., Thacker LR; Massey Cancer Center.; Biostatistics., Deng X; Massey Cancer Center.; Biostatistics., Tombes MB; Massey Cancer Center., Shrader E; Massey Cancer Center., Hudson D; Massey Cancer Center., Bandyopadhyay D; Massey Cancer Center.; Biostatistics., Ryan AA; Massey Cancer Center., Kmieciak M; Massey Cancer Center., Smith S; Pathology., Dent P; Massey Cancer Center.; Biochemistry, Virginia Commonwealth University, Richmond, Virginia, USA. |
| Source: | Anti-cancer drugs [Anticancer Drugs] 2024 Jun 01; Vol. 35 (5), pp. 450-458. Date of Electronic Publication: 2024 Mar 08. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1473-5741 |
|---|---|
| DOI: | 10.1097/CAD.0000000000001584 |
